Cisplatin

cadherin 1 ; Homo sapiens







32 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35443865 The interferon regulatory factor 6 promotes cisplatin sensitivity in colorectal cancer. 2022 Apr 1
2 33478150 Impact of Selected Signaling Proteins on SNAIL 1 and SNAIL 2 Expression in Ovarian Cancer Cell Lines in Relation to Cells' Cisplatin Resistance and EMT Markers Level. 2021 Jan 19 1
3 33921192 Resveratrol Enhances Inhibition Effects of Cisplatin on Cell Migration and Invasion and Tumor Growth in Breast Cancer MDA-MB-231 Cell Models In Vivo and In Vitro. 2021 Apr 12 1
4 34360933 Cisplatin Plus Cetuximab Inhibits Cisplatin-Resistant Human Oral Squamous Cell Carcinoma Cell Migration and Proliferation but Does Not Enhance Apoptosis. 2021 Jul 29 1
5 32710593 Pluripotency transcription factor Nanog and its association with overall oral squamous cell carcinoma progression, cisplatin-resistance, invasion and stemness acquisition. 2020 Nov 1
6 32734935 Curcumin Derivative C086 Combined with Cisplatin Inhibits Proliferation of Osteosarcoma Cells. 2020 Jul 31 1
7 30653577 The effect of sodium butyrate and cisplatin on expression of EMT markers. 2019 2
8 31024010 The PAX6-ZEB2 axis promotes metastasis and cisplatin resistance in non-small cell lung cancer through PI3K/AKT signaling. 2019 Apr 25 1
9 31043583 3-deazaneplanocin A protects against cisplatin-induced renal tubular cell apoptosis and acute kidney injury by restoration of E-cadherin expression. 2019 May 1 1
10 31066485 Chemoresistance in mesenchymal lung cancer cells is correlated to high regulatory T cell presence in the tumor microenvironment. 2019 Jul 2
11 31186697 Impact of EMT in stage IIIB/IV NSCLC treated with erlotinib and bevacizumab when compared with cisplatin, gemcitabine and bevacizumab. 2019 Jun 1
12 31320606 Correction: 3-deazaneplanocin A protects against cisplatin-induced renal tubular cell apoptosis and acute kidney injury by restoration of E-cadherin expression. 2019 Jul 18 1
13 29358506 Blockade of histone deacetylase 6 protects against cisplatin-induced acute kidney injury. 2018 Feb 14 1
14 29515788 CD44 exerts a functional role during EMT induction in cisplatin-resistant head and neck cancer cells. 2018 Feb 9 1
15 29767234 MicroRNA-125a-5p enhances the sensitivity of esophageal squamous cell carcinoma cells to cisplatin by suppressing the activation of the STAT3 signaling pathway. 2018 Aug 2
16 29798292 [Small interference of transcription factor Snail contribute to enhanced cisplatin sensitivity on human laryngeal resistant cancer cells]. 2018 Mar 1
17 29928330 Inhibition of lysine-specific demethylase 1 prevents proliferation and mediates cisplatin sensitivity in ovarian cancer cells. 2018 Jun 1
18 29996940 Simultaneous E-cadherin and PLEKHA7 expression negatively affects E-cadherin/EGFR mediated ovarian cancer cell growth. 2018 Jul 11 1
19 28053596 Celecoxib enhances anticancer effect of cisplatin and induces anoikis in osteosarcoma via PI3K/Akt pathway. 2017 1
20 28212573 Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancer. 2017 Apr 25 2
21 29163683 Knockdown of HMGN5 increases the chemosensitivity of human urothelial bladder cancer cells to cisplatin by targeting PI3K/Akt signaling. 2017 Dec 1
22 27186392 MicroRNA-10b regulates epithelial-mesenchymal transition by modulating KLF4/Notch1/E-cadherin in cisplatin-resistant nasopharyngeal carcinoma cells. 2016 1
23 30091550 [Combined Influence of Arisaematis Rhizoma Polysaccharide with Cisplatin on the Proliferation,Apoptosis and Epithelial Mesenchymal Transition of Breast Carcinoma MDA-MB-231 Cells]. 2016 May 1
24 24935589 Cisplatin combined with metformin inhibits migration and invasion of human nasopharyngeal carcinoma cells by regulating E-cadherin and MMP-9. 2014 1
25 25008268 Construction and characteristics of an E-cadherin-related three-dimensional suspension growth model of ovarian cancer. 2014 Jul 10 1
26 21519793 Ectonucleoside triphosphate diphosphohydrolase 6 expression in testis and testicular cancer and its implication in cisplatin resistance. 2011 Jul 1
27 21618587 Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell-like profile. 2011 Oct 1
28 19584296 Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer. 2009 Jul 15 1
29 17959171 Deletion of exon 8 increases cisplatin-induced E-cadherin cleavage. 2008 Jan 1 3
30 16244579 The role of expression of the components of proteome in the formation of molecular profile of human ovarian carcinoma A2780 cells sensitive and resistant to cisplatin. 2005 Sep 1
31 14985455 Antiadhesive antibodies targeting E-cadherin sensitize multicellular tumor spheroids to chemotherapy in vitro. 2004 Feb 1
32 15138368 Effect of wild-type and mutant E-cadherin on cell proliferation and responsiveness to the chemotherapeutic agents cisplatin, etoposide, and 5-fluorouracil. 2004 4